White House Plan On Drug-Resistant TB Still Pending

Center for Global Health Policy’s “Science Speaks”: Is plan for drug-resistant TB delayed amid cost concerns, while cost of delay goes unnoticed?
Antigone Barton, senior writer and editor of “Science Speaks,” discusses the pending White House plan on drug-resistant tuberculosis, writing, “Now, more than a month after the plan was set to be completed, and with the World Health Organization’s annual report on the global TB epidemic set to be released this week, the status of the plan remains a question…” (10/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.